Everolimus in cardiac-transplant recipients

N Engl J Med. 2003 Dec 4;349(23):2271-2; author reply 2271-2. doi: 10.1056/NEJM200312043492322.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use
  • Coronary Disease / prevention & control
  • Coronary Vessels / pathology
  • Everolimus
  • Graft Rejection / prevention & control*
  • Heart Transplantation / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Kidney Failure, Chronic / chemically induced*
  • Kidney Failure, Chronic / epidemiology
  • Sirolimus / adverse effects*
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use

Substances

  • Immunosuppressive Agents
  • Everolimus
  • Azathioprine
  • Sirolimus